Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Condition:   Early Breast CancerIntervention:   Other: Endocrine therapy interruptionSponsor:   International Breast Cancer Study GroupRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2014 Category: Research Source Type: clinical trials

An Observational Study of Pregnancy And Pregnancy Outcomes in Women With Breast Cancer Treated With Herceptin, Perjeta In Combination With Herceptin, or Kadcyla During Pregnancy or Within 7 Months Prior To Conception (MotHER)
Conditions:   Breast Cancer;   PregnancyIntervention:   Sponsor:   Genentech, Inc.Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2009 Category: Research Source Type: clinical trials